• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4616374)   Today's Articles (685)   Subscriber (49394)
For: Gebski V, Marschner I, Asher R, Byth K. Using recurrent time-to-event models with multinomial outcomes to generate toxicity profiles. Pharm Stat 2021;20:840-849. [PMID: 33733578 DOI: 10.1002/pst.2113] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/21/2020] [Revised: 01/20/2021] [Accepted: 03/02/2021] [Indexed: 12/20/2022]
Number Cited by Other Article(s)
1
Gebski V, Obermair A, Janda M. Toward Incorporating Health-Related Quality of Life as Coprimary End Points in Clinical Trials: Time to Achieve Clinical Important Differences and QoL Profiles. J Clin Oncol 2022;40:2378-2388. [PMID: 35576502 DOI: 10.1200/jco.21.02750] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open
2
Janda M, Obermair A. Fertility-sparing management of early-stage endometrial cancer in reproductive age women: current treatment outcomes and future directions. Int J Gynecol Cancer 2021;31:1506-1507. [PMID: 34785521 DOI: 10.1136/ijgc-2021-003192] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/14/2021] [Accepted: 10/18/2021] [Indexed: 11/03/2022]  Open
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA